Pharmacological treatments

Gosseries, Olivia; Thonnard, M.; Laureys, Steven

doi:10.1007/978-1-4471-2440-5_12

No full text

Contribution to collective works (Parts of books)

Pharmacological treatments

Gosseries, Olivia; Thonnard, M.; Laureys, Steven

2012 • In Coma et états de conscience altérée

Peer reviewed

Permalink
https://hdl.handle.net/2268/243339

DOI
10.1007/978-1-4471-2440-5_12

Files (0)Send to Details Statistics Bibliography Similar publications

Files

Full Text

No document available.

Send to

RIS BibTex APA Chicago Permalink X Linkedin

Details

Abstract :

[en] We review the current state of knowledge for potentially useful drugs acting on the recovery of consciousness in severely brain damaged patients. Exploratory and retrospective studies as well as case reports concerning sporadic cases of spectacular recovery are discussed regarding drugs such as amantadine, levodopa, bromocriptine, apomorphine, methyphenidate, zolpidem, baclofen, sertaline, amitriptyline, desipramine, and lamotrigine. Indications on the underlying mechanisms possibly explaining the effects of these drugs on the awakening and recovery of consciousness are also reported in this challenging population. © 2012 Springer-Verlag London. All rights are reserved.

Disciplines :

Neurology

Author, co-author :

Gosseries, Olivia ; Université de Liège - ULiège > Consciousness-Coma Science Group

Thonnard, M.

Laureys, Steven ; Université de Liège - ULiège > Consciousness-Coma Science Group

Title :

Pharmacological treatments

Publication date :

2012

Main work title :

Coma et états de conscience altérée

Publisher :

Springer-Verlag London Ltd

Pages :

121-138

Peer reviewed :

Peer reviewed

Commentary :

9781447124405; 1447124391; 9781447124399

Available on ORBi :

since 16 January 2020

Statistics

Number of views

34 (0 by ULiège)

Number of downloads

0 (0 by ULiège)

More statistics

Scopus citations^®

Scopus citations^®
without self-citations

OpenCitations

Bibliography

Brown EN, Lydic R, Schiff ND. General anesthesia, sleep and coma. N Engl J Med. 2010;363(27):2638-50.
The Multi-Society Task Force on PVS. Medical aspects of the persistent vegetative state (1). N Engl J Med. 1994;330(21):1499-508.
Giacino JT, Ashwal S, Childs N, et al. The minimally conscious state: definition and diagnostic criteria. Neurology. 2002;58(3):349-53.
Bruno MA, Vanhaudenhuyse A, Thibaut A, Moonen G, Laureys S. From unresponsive wakefulness to minimally conscious PLUS and functional locked-in syndromes: recent advances in our understanding of disorders of consciousness. J Neurol. 2011;258(7):1373-84.
Lombardi F, Taricco M, De Tanti A, Telaro E, Liberati A. Sensory stimulation of brain-injured individuals in coma or vegetative state: results of a Cochrane systematic review, Clin Rehabil. 2002;16(5):464-72.
Zafonte R, Lexell J, Cullen N. Possible applications for dopaminergic agents following traumatic brain injury: part 2. J Head Trauma Rehabil. 2001;16(1):112-6.
Born JD. The Glasgow-Liège Scale. Prognostic value and evaluation of motor response and brain stem reflexes after severe head injury. Acta Neurochir. 1988;95:49-52.
Saniova B, Drobny M, Kneslova L, et al. The outcome of patients with severe head injuries treated with amantadine sulphate. J Neural Transm. 2004;111(4):511-4.
Folstein M, Robins L, Helzer J. The mini-mental state examination. Arch Gen Psychiatry. 1983;40(7):812.
Jennett B, Bond M. Assessment of outcome after severe brain damage. Lancet. 1975; 1(7905):480-4.
Rappaport M, Hall KM, Hopkins K, et al. Disability rating scale for severe head trauma: coma to community. Arch Phys Med Rehabil. 1982;63(3):118-23.
Meythaler JM, Brunner RC, Johnson A, et al. Amantadine to improve neurorecovery in traumatic brain injury-associated diffuse axonal injury: a pilot double-blind randomized trial. J Head Trauma Rehabil. 2002;17(4):300-13.
Rappaport M. The coma/near coma scale. 2000. Retrieved 21 Aug 21, 2006, from http://www.tbims.org/combi/cnc
Zafonte R, Watanabe T, Mann N. Amantadine: a potential treatment for the minimally conscious state. Brain Inj. 1998;12(7):617-21.
Giacino JT, Kalmar K, Whyte J. The JFK Coma Recovery Scale-Revised: measurement characteristics and diagnostic utility. Arch Phys Med Rehabil. 2004;85(12):2020-9.
Schnakers C, Hustinx R, Vandewalle G, et al. Measuring the effect of amantadine in chronic anoxic minimally conscious state. J Neurol Neurosurg Psychiatry. 2008;79(2):225-7.
Gualtieri T, Chandler M, Coons T, et al. Amantadine: a new clinical profile for traumatic brain injury. Clin Neuropharmacol. 1989;12(4):258-70.
Ansell BJ, Keenan JE. The Western Neuro Sensory Stimulation Profile: a tool for assessing slow-to-recover head-injured patients. Arch Phys Med Rehabil. 1989;70(2):104-8.
Patrick P, Blackman J, Mabry J, et al. Dopamine agonist therapy in low-response children following traumatic brain injury. J Child Neurol. 2006;21(10):879-85.
Hughes S, Colantonio A, Santaguida P, et al. Amantadine to enhance readiness for rehabilitation following severe traumatic brain injury. Brain Inj. 2005;19(14):1197-206.
Laureys S, Piret S, Ledoux D. Quantifying consciousness. Lancet Neurol. 2005;4(12): 789-90.
Haig A, Ruess J. Recovery from vegetative state of six months' duration associated with Sinemet (levodopa/carbidopa). Arch Phys Med Rehabil. 1990;71(13):1081-3.
Matsuda W, Matsumura A, Komatsu Y, et al. Awakenings from persistent vegetative state: report of three cases with parkinsonism and brain stem lesions on MRI. J Neurol Neurosurg Psychiatry. 2003;74(11):1571-3.
Matsuda W, Komatsu Y, Yanaka K, et al. Levodopa treatment for patients in persistent vegetative or minimally conscious states. Neuropsychol Rehabil. 2005;15(3-4):414-27.
Krimchansky B, Keren O, Sazbon L, et al. Differential time and related appearance of signs, indicating improvement in the state of consciousness in vegetative state traumatic brain injury (VS-TBI) patients after initiation of dopamine treatment. Brain Inj. 2004;18(11):1099-105.
Passler MA, Riggs RV. Positive outcomes in traumatic brain injury-vegetative state: patients treated with bromocriptine. Arch Phys Med Rehabil. 2001;82(3):311-5.
Fridman E, Calvar J, Bonetto M, et al. Fast awakening from minimally conscious state with apomorphine. Brain Inj. 2009;23(2):172-7.
Fridman E, Krimchansky B, Bonetto M, et al. Continuous subcutaneous apomorphine for severe disorders of consciousness after traumatic brain injury. Brain Inj. 2010;24(4):636-41.
Chew E, Zafonte R. Pharmacological management of neurobehavioral disorders following traumatic brain injury-a state-of-the-art review. J Rehabil Res Dev. 2009;46(6):851-79.
Moein H, Khalili H, Keramatian K. Effect of methylphenidate on ICU and hospital length of stay in patients with severe and moderate traumatic brain injury. Clin Neurol Neurosurg. 2006;108(6):539-42.
Martin R, Whyte J. The effects of methylphenidate on command following and yes/no communication in persons with severe disorders of consciousness: a meta-analysis of n-of-1 studies. Am J Phys Med Rehabil. 2007;86(8):613-20.
Gualtieri C, Evans R. Stimulant treatment for the neurobehavioural sequelae of traumatic brain injury. Brain Inj. 1988;2(4):273-90.
Whyte J, Hart T, Vaccaro M, et al. Effects of methylphenidate on attention deficits after traumatic brain injury: a multidimensional, randomized, controlled trial. Am J Phys Med Rehabil. 2004;83(6):401-20.
Patrick P, Buck M, Conaway M, et al. The use of dopamine enhancing medications with children in low response states following brain injury. Brain Inj. 2003;17(6):497-506.
Clauss RP, Guldenpfennig WM, Nel HW, et al. Extraordinary arousal from semi-comatose state on zolpidem. A case report. S Afr Med J. 2000;90(1):68-72.
Clauss R, Nel W. Drug induced arousal from the permanent vegetative state. NeuroRehabilitation. 2006;21(1):23-8.
Hagen C, Malkmus D, Durham P. Levels of cognitive functioning. Downey: Rancho Los Amigos Hospital Inc.; 1987.
Brefel-Courbon C, Payoux P, Ory F, et al. Clinical and imaging evidence of zolpidem effect in hypoxic encephalopathy. Ann Neurol. 2007;62(1):102-5.
Cohen SI, Duong TT. Increased arousal in a patient with anoxic brain injury after administration of zolpidem. Am J Phys Med Rehabil. 2008;87(3):229-31.
Shames JL, Ring H. Transient reversal of anoxic brain injury-related minimally conscious state after zolpidem administration: a case report. Arch Phys Med Rehabil. 2008;89(2):386-8.
Whyte J, Myers R. Incidence of clinically significant responses to zolpidem among patients with disorders of consciousness: a preliminary placebo controlled trial. Am J Phys Med Rehabil. 2009;88(5):410-8.
Lo Y, Tan E, Ratnagopal P, et al. Zolpidem and its effects on hypoxic encephalopathy. Ann Neurol. 2008;64(4):477-8.
Singh R, McDonald C, Dawson K, et al. Zolpidem in a minimally conscious state. Brain Inj. 2008;22(1):103-6.
Cohen L, Chaaban B, Habert MO. Transient improvement of aphasia with zolpidem. N Engl J Med. 2004;350(9):949-50.
Clauss RP, Nel WH. Effect of zolpidem on brain injury and diaschisis as detected by 99mTc HMPAO brain SPECT in humans. Arzneimittelforschung. 2004;54(10):641-6.
Hall S, Yamawaki N, Fisher A, et al. GABA(A) alpha-1 subunit mediated desynchronization of elevated low frequency oscillations alleviates specific dysfunction in stroke-a case report. Clin Neurophysiol. 2010;121(4):549-55.
Schiff N. Recovery of consciousness after brain injury: a mesocircuit hypothesis. Trends Neurosci. 2010;33(1):1-9.
Kawecki Z, Kwiatkowski S, Grzegorzewski P, et al. Sudden improvement of all neurological functions after general anesthesia and two-day intrathecal infusion of baclofen in a child with primary brain-stem injury. Przegl Lek. 2007;64(2):13-4.
Sarà M, Sacco S, Cipolla F, et al. An unexpected recovery from permanent vegetative state. Brain Inj. 2007;21(1):101-3.
Taira T, Hori T. Intrathecal baclofen in the treatment of post-stroke central pain, dystonia, and persistent vegetative state. Acta Neurochir Suppl. 2007;97(Pt 1):227-9.
Sarà M, Pistoia F, Mura E, et al. Intrathecal baclofen in patients with persistent vegetative state: 2 hypotheses. Arch Phys Med Rehabil. 2009;90(7):1245-9.
Taira T. Intrathecal administration of GABA agonists in the vegetative state. Prog Brain Res. 2009;177:317-28.
Meythaler J, Depalma L, Devivo M, et al. Sertraline to improve arousal and alertness in severe traumatic brain injury secondary to motor vehicle crashes. Brain Inj. 2001;15(4):321-31.
Reinhard D, Whyte J, Sandel M. Improved arousal and initiation following tricyclic antidepressant use in severe brain injury. Arch Phys Med Rehabil. 1996;77(1):80-3.
Showalter P, Kimmel D. Stimulating consciousness and cognition following severe brain injury: a new potential clinical use for lamotrigine. Brain Inj. 2000;14:997-1001.
Clauss R. Neurotransmitters in coma, vegetative and minimally conscious states, pharmacological interventions. Med Hypotheses. 2010;75(3):287-90.
Schiff N. Recovery of consciousness after severe brain injury: the role of arousal regulation mechanisms and some speculation on the heart-brain interface. Cleve Clin J Med. 2010;77 Suppl 3:S27-33.
Laureys S, Schiff N. Coma and consciousness: paradigms (re)framed by neuroimaging. Neuroimage. 2011 Dec 27. [Epub ahead of print]
Pistoia F, Mura E, Govoni S, et al. Awakenings and awareness recovery in disorders of consciousness: is there a role for drugs? CNS Drugs. 2010;24(8):625-38.
American Congress of Rehabilitation Medicine, Brain Injury-Interdisciplinary Special Interest Group, Disorders of Consciousness Task Force, Seel R, Sherer M, Whyte J, Katz D, Giacino J, Rosenbaum A, Hammond F, Kalmar K, Pape T, Zafonte R, Biester R, Kaelin D, Kean J, Zasler N. Assessment scales for disorders of consciousness: evidence-based recommendations for clinical practice and research. Arch Phys Med Rehabil. 2010;91(12):1795-813.
Schiff ND, Giacino JT, Kalmar K, et al. Behavioural improvements with thalamic stimulation after severe traumatic brain injury. Nature. 2007;448(7153):600-3.